Cargando…

Non-coding RNAs in cancer-associated cachexia: clinical implications and future perspectives

Cachexia is a multifactorial syndrome characterized by skeletal muscle loss, with or without adipose atrophy, irreversible through nutritional support, in the context of systemic inflammation and metabolic disorders. It is mediated by inflammatory reaction and affects almost 50% of all cancer patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kottorou, Anastasia, Dimitrakopoulos, Foteinos-Ioannis, Tsezou, Aspasia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100623/ https://www.ncbi.nlm.nih.gov/pubmed/33915516 http://dx.doi.org/10.1016/j.tranon.2021.101101

Ejemplares similares

Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2020)

Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients
por: Kottorou, Anastasia, et al.
Publicado: (2023)

Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives
por: Zografos, Eleni, et al.
Publicado: (2022)

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2020)

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2021)

Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development
por: Antonacopoulou, Anna, et al.
Publicado: (2020)

Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia
por: Donzelli, Sara, et al.
Publicado: (2020)

MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools
por: Kyriakidis, Ioannis, et al.
Publicado: (2022)

NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2018)

The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia
por: Santos, Joana M. O., et al.
Publicado: (2020)

Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem
por: Dimitrakopoulos, Fotinos-Ioannis D., et al.
Publicado: (2015)

Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients
por: Dimitrakopoulos, Foteinos-Ioannis D., et al.
Publicado: (2019)

Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer Patients
por: Kottorou, Anastasia E., et al.
Publicado: (2020)

Regulation of Skeletal Muscle Atrophy in Cachexia by MicroRNAs and Long Non-coding RNAs
por: Chen, Rui, et al.
Publicado: (2020)

Clinical Significance of Plasma CD9-Positive Exosomes in HIV Seronegative and Seropositive Lung Cancer Patients
por: Dimitrakopoulos, Foteinos-Ioannis, et al.
Publicado: (2021)

Cadherin and Wnt signaling pathways as key regulators in diabetic nephropathy
por: Tziastoudi, Maria, et al.
Publicado: (2021)

Non-coding RNAs in exosomes and adipocytes cause fat loss during cancer cachexia
por: Du, Guannan, et al.
Publicado: (2021)

Non-Coding RNAs and Human Diseases: Current Status and Future Perspectives
por: Niderla-Bielińska, Justyna, et al.
Publicado: (2023)

Circulating long non-coding RNAs in cancer: current status and future perspectives
por: Qi, Peng, et al.
Publicado: (2016)

Radical Tumor Denervation Activates Potent Local and Global Cancer Treatment
por: Mitsou, John D., et al.
Publicado: (2023)

Cancer Cachexia: Mechanisms and Clinical Implications
por: Donohoe, Claire L., et al.
Publicado: (2011)

Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017)

Long non-coding RNAs in cutaneous melanoma: clinical perspectives
por: Hulstaert, Eva, et al.
Publicado: (2017)

Cancer Cachexia and MicroRNAs
por: Camargo, Rodolfo Gonzalez, et al.
Publicado: (2015)

Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives
por: Zwickl, Hannes, et al.
Publicado: (2019)

Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas
por: Kottorou, Anastasia E., et al.
Publicado: (2018)

Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications
por: Zhao, Weihong, et al.
Publicado: (2014)

Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications
por: Elia, Leonardo, et al.
Publicado: (2017)

The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer
por: Yue, Yanping, et al.
Publicado: (2021)

Non-Coding RNAs in Stem Cell Regulation and Cardiac Regeneration: Current Problems and Future Perspectives
por: Schweiger, Victor, et al.
Publicado: (2021)

Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients
por: Roumeliotou, Argyro, et al.
Publicado: (2022)

Noncoding RNAs related to the hedgehog pathway in cancer: clinical implications and future perspectives
por: Song, Jia, et al.
Publicado: (2022)

Long non-coding RNAs and their implications in cancer epigenetics
por: Beckedorff, Felipe C., et al.
Publicado: (2013)

Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
por: Niu, Zhao-Shan, et al.
Publicado: (2017)

Perspectives of Long Non-Coding RNAs in Cancer Diagnostics
por: Reis, Eduardo M., et al.
Publicado: (2012)

Bone morphogenetic protein-2-induced Wnt/β-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes
por: Papathanasiou, Ioanna, et al.
Publicado: (2012)

Cancer cachexia: an orphan with a future
por: Lainscak, Mitja, et al.
Publicado: (2019)

Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives
por: Ranga, Shalu, et al.
Publicado: (2023)

Histone code and long non-coding RNAs (lncRNAs) aberrations in lung cancer: implications in the therapy response
por: Herrera-Solorio, Abril Marcela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o3s9959mjgk9remc9r2u1jh85n